Greenwood, IN, United States of America

Bishnu Thapa

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bishnu Thapa. Retrieved from https://idiyas.com/inventor/bishnu-thapa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bishnu Thapa

Introduction

Bishnu Thapa is an accomplished inventor based in Greenwood, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on ATR antagonists. His research and inventions have the potential to impact various therapeutic areas.

Latest Patents

Bishnu Thapa holds a patent for ATR antagonists and their uses. This invention provides certain piperidine compounds as ATR antagonists, specifically compounds of formula (I). This patent represents a notable advancement in the development of new therapeutic agents.

Career Highlights

Thapa is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to focus on groundbreaking research and development in the pharmaceutical sector. His dedication to innovation is evident in his contributions to the field.

Collaborations

Bishnu Thapa has collaborated with notable colleagues, including Thomas James Beauchamp and Zhaogen Chen. These collaborations have fostered a productive environment for research and innovation, leading to advancements in their respective fields.

Conclusion

Bishnu Thapa's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of ATR antagonists, highlight the importance of research and collaboration in developing new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…